Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Receivables (2016 - 2025)

INVO Fertility (IVF) has disclosed Receivables for 15 consecutive years, with $274200.0 as the latest value for Q3 2025.

  • Quarterly Receivables rose 6.67% to $274200.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $274200.0 through Sep 2025, up 6.67% year-over-year, with the annual reading at $22500.0 for FY2024, 83.99% down from the prior year.
  • Receivables for Q3 2025 was $274200.0 at INVO Fertility, up from $37500.0 in the prior quarter.
  • The five-year high for Receivables was $807811.0 in Q1 2021, with the low at $13500.0 in Q4 2022.
  • Average Receivables over 5 years is $138787.2, with a median of $71311.0 recorded in 2022.
  • The sharpest move saw Receivables soared 21738.63% in 2021, then tumbled 97.05% in 2022.
  • Over 5 years, Receivables stood at $16310.0 in 2021, then fell by 17.23% to $13500.0 in 2022, then surged by 941.11% to $140550.0 in 2023, then crashed by 83.99% to $22500.0 in 2024, then skyrocketed by 1118.67% to $274200.0 in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $274200.0, $37500.0, and $173614.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.